AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (689.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Progress in research into spinal cord injury repair: Tissue engineering scaffolds and cell transdifferentiation

Changke Ma§,1Peng Zhang§,2Yixin Shen2( )
Department of Orthopaedics, The People's Hospital of Luhe, Nanjing 211500, Jiangsu, China
Department of Orthopaedics, The Second Affiliated Hospital of Soochow University, Suzhou 215004, Jiangsu, China

§ These authors contributed equally to this work.

Show Author Information

Abstract

As with all tissues of the central nervous system, the low regeneration ability of spinal cord tissue after injury decreases the potential for repair and recovery. Initially, in spinal cord injuries (SCI), often the surgeon can only limit further damage by early surgical decompression. However, with the development of basic science, especially the development of genetic engineering, molecular biology, tissue engineering, and materials science, some promising progress has been made in promoting the repair of central nervous system injuries. For example, transplantation of neural stem cells (NSCs), olfactory ensheathing cells (OECs), and gene- mediated transdifferentiation to repair central nervous system injury. This paper summarizes the progress and prospects of SCI repair with tissue engineering scaffold and cell transdifferentiation from an extensive literatures.

References

[1]
AE Smith, IR Molton, MP Jensen. Self-reported incidence and age of onset of chronic comorbid medical conditions in adults aging with long-term physical disability. Disabil Health J. 2016, 9(3): 533-538.
[2]
JT Street, VK Noonan, A Cheung, et al. Incidence of acute care adverse events and long-term health-related quality of life in patients with TSCI. Spine J. 2015, 15(5): 923-932.
[3]
H Chikuda, J Ohya, H Horiguchi, et al. Ischemic stroke after cervical spine injury: analysis of 11, 005 patients using the Japanese diagnosis procedure combination database. Spine J. 2014, 14(10): 2275-2280.
[4]
S Piran, S Schulman. Incidence and risk factors for venous thromboembolism in patients with acute spinal cord injury: A retrospective study. Thromb Res. 2016, 147: 97-101.
[5]
G Li, MT Che, X Zeng, et al. Neurotrophin-3 released from implant of tissue-engineered fibroin scaffolds inhibits inflammation, enhances nerve fiber regeneration, and improves motor function in canine spinal cord injury. J Biomed Mater Res. 2018, 106(8): 2158-2170.
[6]
MA Anderson, JE Burda, YL Ren, et al. Astrocyte scar formation aids central nervous system axon regeneration. Nature. 2016, 532(7598): 195-200.
[7]
ME Schwab, C Brösamle. Regeneration of lesioned corticospinal tract fibers in the adult rat spinal cord under experimental conditions. Spinal Cord. 1997, 35(7): 469-473.
[8]
A Shafiee, A Atala. Printing technologies for medical applications. Trends Mol Med. 2016, 22(3): 254-265.
[9]
LJ Wang, Q Shi, JW Dai, et al. Increased vascularization promotes functional recovery in the transected spinal cord rats by implanted vascular endothelial growth factor-targeting collagen scaffold. J Orthop Res. 2018, 36(3): 1024-1034.
[10]
LTA Hong, YM Kim, HH Park, et al. An injectable hydrogel enhances tissue repair after spinal cord injury by promoting extracellular matrix remodeling. Nat Commun. 2017, 8(1): 533.
[11]
M Boido, M Ghibaudi, P Gentile, et al. Chitosan- based hydrogel to support the paracrine activity of mesenchymal stem cells in spinal cord injury treatment. Sci Rep. 2019, 9(1): 6402.
[12]
R Deumens, GC Koopmans, WM Honig, et al. Chronically injured corticospinal axons do not cross large spinal lesion gaps after a multifactorial transplantation strategy using olfactory ensheathing cell/ olfactory nerve fibroblast-biomatrix bridges. J Neurosci Res. 2006, 83(5): 811-820.
[13]
D Cigognini, D Silva, S Paloppi, et al. Evaluation of mechanical properties and therapeutic effect of injectable self-assembling hydrogels for spinal cord injury. J Biomed Nanotechnol. 2014, 10(2): 309-323.
[14]
B Ghosh, J Nong, ZC Wang, et al. A hydrogel engineered to deliver minocycline locally to the injured cervical spinal cord protects respiratory neural circuitry and preserves diaphragm function. Neurobiol Dis. 2019, 127: 591-604.
[15]
Y Liu, H Ye, K Satkunendrarajah, et al. A self- assembling peptide reduces glial scarring, attenuates post-traumatic inflammation and promotes neurological recovery following spinal cord injury. Acta Biomater. 2013, 9(9): 8075-8088.
[16]
MF Rauch, SR Hynes, J Bertram, et al. Engineering angiogenesis following spinal cord injury: a coculture of neural progenitor and endothelial cells in a degradable polymer implant leads to an increase in vessel density and formation of the blood-spinal cord barrier. Eur J Neurosci. 2009, 29(1): 132-145.
[17]
J Arulmoli, HJ Wright, DTT Phan, et al. Combination scaffolds of salmon fibrin, hyaluronic acid, and laminin for human neural stem cell and vascular tissue engineering. Acta Biomater. 2016, 43: 122-138.
[18]
L Xue, HP Greisler. Angiogenic effect of fibroblast growth factor-1 and vascular endothelial growth factor and their synergism in a novel in vitro quantitative fibrin-based 3-dimensional angiogenesis system. Surgery. 2002, 132(2): 259-267.
[19]
ME Kroon, ML van Schie, B van der Vecht, et al. Collagen type 1 retards tube formation by human microvascular endothelial cells in a fibrin matrix. Angiogenesis. 2002, 5(4): 257-265.
[20]
J Chedly, S Soares, A Montembault, et al. Physical chitosan microhydrogels as scaffolds for spinal cord injury restoration and axon regeneration. Biomaterials. 2017, 138: 91-107.
[21]
CG Zeng, Y Xiong, GY Xie, et al. Fabrication and evaluation of PLLA multichannel conduits with nanofibrous microstructure for the differentiation of NSCs in vitro. Tissue Eng Part A. 2014, 20(5/6): 1038-1048.
[22]
X Zeng, YS Zeng, YH Ma, et al. Bone marrow mesenchymal stem cells in a three-dimensional gelatin sponge scaffold attenuate inflammation, promote angiogenesis, and reduce cavity formation in experimental spinal cord injury. Cell Transplant. 2011, 20(11/12): 1881-1899.
[23]
M Jalali Monfared, F Nasirinezhad, S Ebrahimi-Barough, et al. Transplantation of miR-219 overexpressed human endometrial stem cells encapsulated in fibrin hydrogel in spinal cord injury. J Cell Physiol. 2019, 234(10): 18887-18896.
[24]
HM Duan, WH Ge, AF Zhang, et al. Transcriptome analyses reveal molecular mechanisms underlying functional recovery after spinal cord injury. Proc Natl Acad Sci USA. 2015, 112(43): 13360-13365.
[25]
HR Ko, IS Kwon, I Hwang, et al. Akt1-Inhibitor of DNA binding2 is essential for growth cone formation and axon growth and promotes central nervous system axon regeneration. Elife. 2016, 5: e20799.
[26]
S Neumann, CJ Woolf. Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron. 1999, 23(1): 83-91.
[27]
Y Epstein, N Perry, M Volin, et al. MiR-9a modulates maintenance and ageing of Drosophila germline stem cells by limiting N-cadherin expression. Nat Commun. 2017, 8(1): 600.
[28]
TY Wang, WQ Yuan, Y Liu, et al. MiR-142-3p is a potential therapeutic target for sensory function recovery of spinal cord injury. Med Sci Monit. 2015, 21: 2553-2556.
[29]
TY Wang, Y Liu, WQ Yuan, et al. Identification of microRNAome in rat bladder reveals miR-1949 as a potential inducer of bladder cancer following spinal cord injury. Mol Med Rep. 2015, 12(2): 2849-2857.
[30]
TG Hauk, M Leibinger, A Müller, et al. Stimulation of axon regeneration in the mature optic nerve by intravitreal application of the toll-like receptor 2 agonist Pam3Cys. Invest Ophthalmol Vis Sci. 2010, 51(1): 459-464.
[31]
K Nagata, I Hama, S Kiryu-Seo, et al. MicroRNA-124 is down regulated in nerve-injured motor neurons and it potentially targets mRNAs for KLF6 and STAT3. Neuroscience. 2014, 256: 426-432.
[32]
R Kumar, SK Sahu, M Kumar, et al. MicroRNA 17-5p regulates autophagy in Mycobacterium tuberculosis- infected macrophages by targeting Mcl-1 and STAT3. Cell Microbiol. 2016, 18(5): 679-691.
[33]
JZ Hu, JH Huang, L Zeng, et al. Anti-apoptotic effect of microRNA-21 after contusion spinal cord injury in rats. J Neurotrauma. 2013, 30(15): 1349-1360.
[34]
D Sayed, MZ He, C Hong, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010, 285(26): 20281-20290.
[35]
OG Bhalala, LL Pan, V Sahni, et al. MicroRNA-21 regulates astrocytic response following spinal cord injury. J Neurosci. 2012, 32(50): 17935-17947.
[36]
JL Song, W Zheng, W Chen, et al. Lentivirus- mediated microRNA-124 gene-modified bone marrow mesenchymal stem cell transplantation promotes the repair of spinal cord injury in rats. Exp Mol Med. 2017, 49(5): e332.
[37]
P Dergham, B Ellezam, C Essagian, et al. Rho signaling pathway targeted to promote spinal cord repair. J Neurosci. 2002, 22(15): 6570-6577.
[38]
S Conrad, HJ Schluesener, K Trautmann, et al. Prolonged lesional expression of RhoA and RhoB following spinal cord injury. J Comp Neurol. 2005, 487(2): 166-175.
[39]
MK Jee, JS Jung, JI Choi, et al. MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury. Brain. 2012, 135(Pt 4): 1237-1252.
[40]
D Tosh, JM Slack. How cells change their phenotype. Nat Rev Mol Cell Biol. 2002, 3(3): 187-194.
[41]
A Cieślar-Pobuda, V Knoflach, MV Ringh, et al. Transdifferentiation and reprogramming: Overview of the processes, their similarities and differences. Biochim Biophys Acta Mol Cell Res. 2017, 1864(7): 1359-1369.
[42]
MR Wada, M Inagawa-Ogashiwa, S Shimizu, et al. Generation of different fates from multipotent muscle stem cells. Development. 2002, 129(12): 2987-2995.
[43]
J Xu, YY Du, HK Deng. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell. 2015, 16(2): 119-134.
[44]
M Bierlein De la Rosa, AD Sharma, SK Mallapragada, et al. Transdifferentiation of brain-derived neurotrophic factor (BDNF)-secreting mesenchymal stem cells significantly enhance BDNF secretion and Schwann cell marker proteins. J Biosci Bioeng. 2017, 124(5): 572-582.
[45]
SW Shen, CL Duan, XH Chen, et al. Neurogenic effect of VEGF is related to increase of astrocytes transdifferentiation into new mature neurons in rat brains after stroke. Neuropharmacology. 2016, 108: 451-461.
[46]
S Wang, Y Jung, J Hyun, et al. RNA binding proteins control transdifferentiation of hepatic stellate cells into myofibroblasts. Cell Physiol Biochem. 2018, 48(3): 1215-1229.
[47]
A Prasad, DB Teh, FR Shah Jahan, et al. Direct conversion through trans-differentiation: efficacy and safety. Stem Cells Dev. 2017, 26(3): 154-165.
[48]
YG Liu, QL Miao, JC Yuan, et al. Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo. J Neurosci. 2015, 35(25): 9336-9355.
[49]
AR Bonilla-Porras, C Velez-Pardo, M Jimenez-Del-Rio. Fast transdifferentiation of human Wharton’s jelly mesenchymal stem cells into neurospheres and nerve-Like cells. J Neurosci Methods. 2017, 282: 52-60.
[50]
S Kleiderman, S Gutbier, K Ugur Tufekci, et al. Conversion of nonproliferating astrocytes into neurogenic neural stem cells: control by FGF2 and interferon-Γ. Stem Cells. 2016, 34(12): 2861-2874.
[51]
L Kurian, I Sancho-Martinez, E Nivet, et al. Conversion of human fibroblasts to angioblast-Like progenitor cells. Nat Methods. 2013, 10(1): 77-83.
[52]
MS Lim, MY Chang, SM Kim, et al. Generation of dopamine neurons from rodent fibroblasts through the expandable neural precursor cell stage. J Biol Chem. 2015, 290(28): 17401-17414.
[53]
MC Doeser, HR Schöler, GM Wu. Reduction of fibrosis and scar formation by partial reprogramming in vivo. Stem Cells. 2018, 36(8): 1216-1225.
[54]
M Pekny, U Wilhelmsson, T Tatlisumak, et al. Astrocyte activation and reactive gliosis-A new target in stroke? Neurosci Lett. 2019, 689: 45-55.
[55]
J Frik, J Merl-Pham, N Plesnila, et al. Cross-talk between monocyte invasion and astrocyte proliferation regulates scarring in brain injury. EMBO Rep. 2018, 19(5): e45294.
[56]
MC Falo, HL Fillmore, TM Reeves, et al. Matrix metalloproteinase-3 expression profile differentiates adaptive and maladaptive synaptic plasticity induced by traumatic brain injury. J Neurosci Res. 2006, 84(4): 768-781.
[57]
G Yin, MJ Du, R Li, et al. Glia maturation factor beta is required for reactive gliosis after traumatic brain injury in zebrafish. Exp Neurol. 2018, 305: 129-138.
[58]
CH Chen, XL Zhong, DK Smith, et al. Astrocyte- specific deletion of Sox2 promotes functional recovery after traumatic brain injury. Cereb Cortex. 2019, 29(1): 54-69.
[59]
M Faiz, N Sachewsky, S Gascón, et al. Adult neural stem cells from the subventricular zone give rise to reactive astrocytes in the cortex after stroke. Cell Stem Cell. 2015, 17(5): 624-634.
[60]
ZY Guo, L Zhang, Z Wu, et al. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model. Cell Stem Cell. 2014, 14(2): 188-202.
[61]
JP Magnusson, C Göritz, J Tatarishvili, et al. A latent neurogenic program in astrocytes regulated by Notch signaling in the mouse. Science. 2014, 346(6206): 237-241.
[62]
S Sirko, G Behrendt, PA Johansson, et al. Reactive Glia in the injured brain acquire stem cell properties in response to sonic hedgehog. [corrected]. Cell Stem Cell. 2013, 12(4): 426-439.
[63]
L Cao, L Liu, ZY Chen, et al. Olfactory ensheathing cells genetically modified to secrete GDNF to promote spinal cord repair. Brain. 2004, 127(Pt 3): 535-549.
[64]
K Fouad, L Schnell, MB Bunge, et al. Combining Schwann cell bridges and olfactory-ensheathing Glia grafts with chondroitinase promotes locomotor recovery after complete transection of the spinal cord. J Neurosci. 2005, 25(5): 1169-1178.
Journal of Neurorestoratology
Pages 196-206
Cite this article:
Ma C, Zhang P, Shen Y. Progress in research into spinal cord injury repair: Tissue engineering scaffolds and cell transdifferentiation. Journal of Neurorestoratology, 2019, 7(4): 196-206. https://doi.org/10.26599/JNR.2019.9040024

1056

Views

100

Downloads

11

Crossref

13

Web of Science

0

Scopus

Altmetrics

Received: 19 September 2019
Revised: 27 November 2019
Accepted: 09 December 2019
Published: 17 January 2020
© The authors 2019

This article is published with open access at http://jnr.tsinghuajournals.com

Return